Matches in Wikidata for { <http://www.wikidata.org/entity/Q90068704> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q90068704 description "article scientifique publié en 2017" @default.
- Q90068704 description "artículu científicu espublizáu en xunu de 2017" @default.
- Q90068704 description "scientific article published on 01 June 2017" @default.
- Q90068704 description "wetenschappelijk artikel" @default.
- Q90068704 description "наукова стаття, опублікована в червні 2017" @default.
- Q90068704 name "Ramucirumab plus pembrolizumab in previously treated advanced or metastatic biliary tract cancer: A multi-disease phase 1 study" @default.
- Q90068704 name "Ramucirumab plus pembrolizumab in previously treated advanced or metastatic biliary tract cancer: A multi-disease phase 1 study" @default.
- Q90068704 type Item @default.
- Q90068704 label "Ramucirumab plus pembrolizumab in previously treated advanced or metastatic biliary tract cancer: A multi-disease phase 1 study" @default.
- Q90068704 label "Ramucirumab plus pembrolizumab in previously treated advanced or metastatic biliary tract cancer: A multi-disease phase 1 study" @default.
- Q90068704 prefLabel "Ramucirumab plus pembrolizumab in previously treated advanced or metastatic biliary tract cancer: A multi-disease phase 1 study" @default.
- Q90068704 prefLabel "Ramucirumab plus pembrolizumab in previously treated advanced or metastatic biliary tract cancer: A multi-disease phase 1 study" @default.
- Q90068704 P1433 Q90068704-256947AF-00C3-4CDE-B329-11AE9D6F384F @default.
- Q90068704 P1476 Q90068704-5F96DBEC-074B-4BBA-8086-056C748EABCC @default.
- Q90068704 P2093 Q90068704-0609B365-089A-45BA-BDF8-8B2C4658680C @default.
- Q90068704 P2093 Q90068704-17D801AD-628B-4145-92B1-28AFFFF25F8F @default.
- Q90068704 P2093 Q90068704-1D6358F8-E008-433B-BDC0-DEB4B06A5B7A @default.
- Q90068704 P2093 Q90068704-473E04CF-CDF6-46EE-BE8F-D121A20A5CCB @default.
- Q90068704 P2093 Q90068704-794A1637-68B7-41B1-864E-43BF38BDE8F5 @default.
- Q90068704 P2093 Q90068704-86879429-AD28-4580-8168-D7A39AACCAB5 @default.
- Q90068704 P2093 Q90068704-98E8989C-8DA6-4499-99EA-A22211412BFD @default.
- Q90068704 P304 Q90068704-C7391926-41A9-4969-A96A-158489A7A0B9 @default.
- Q90068704 P31 Q90068704-F62E46DE-FA0F-42D2-AE43-8304CE411170 @default.
- Q90068704 P356 Q90068704-711247D9-E644-4BE3-BC23-3E2F5368A88F @default.
- Q90068704 P478 Q90068704-F3D14A2F-80B4-47E6-9305-123B41369A20 @default.
- Q90068704 P50 Q90068704-E4696674-73D9-4A86-ACC4-4C150621C3ED @default.
- Q90068704 P577 Q90068704-ED340785-210A-447E-8985-6322072829E3 @default.
- Q90068704 P921 Q90068704-16D11A21-FB76-4CE4-B75A-BF9F02CCB610 @default.
- Q90068704 P921 Q90068704-DFF5C5D1-3A29-4786-9001-C0408C4615DF @default.
- Q90068704 P356 MDX262.018 @default.
- Q90068704 P1433 Q326122 @default.
- Q90068704 P1476 "Ramucirumab plus pembrolizumab in previously treated advanced or metastatic biliary tract cancer: A multi-disease phase 1 study" @default.
- Q90068704 P2093 "David Ferry" @default.
- Q90068704 P2093 "Gu Mi" @default.
- Q90068704 P2093 "Hendrik-Tobias Arkenau" @default.
- Q90068704 P2093 "Ian Chau" @default.
- Q90068704 P2093 "Jessicca Rege" @default.
- Q90068704 P2093 "Jin Jin" @default.
- Q90068704 P2093 "Johanna Bendell" @default.
- Q90068704 P304 "iii144-iii145" @default.
- Q90068704 P31 Q13442814 @default.
- Q90068704 P356 "10.1093/ANNONC/MDX262.018" @default.
- Q90068704 P478 "28 Suppl 3" @default.
- Q90068704 P50 Q89006575 @default.
- Q90068704 P577 "2017-06-01T00:00:00Z" @default.
- Q90068704 P921 Q13896859 @default.
- Q90068704 P921 Q18556397 @default.